• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·VLNS.TO
Share

The Valens Company Inc. Stocks

CA$ 0Last Updated 23.03.2026

Issuer Rating

Performance

Modest

Risk

Low

Recommendation

Sell

CA$ 0
Key Takeaways

Risk factor

Considerable default risk

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles, natural health, and other products. In addition, it offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, product development, and custom manufacturing services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

04.08.2026 13:39

Chinese AI developers have created a "death zone" for Anthropic and OpenAI

04.08.2026 12:26

Oninvest Index: Quantum small-caps have lost most of their gains. Is this the end of the rally?

04.08.2026 11:53

SpaceX at $100? In the coming days, the market will put Musk's strategy to the test

04.08.2026 11:36

Microsoft stock is on its best rally in 26 years. Is it too late to buy?

04.08.2026 10:59

Why Did Kazatomprom Increase Production and Decrease Sales?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026